Clinical Trial: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07490041) titled 'Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases' on March 18.

Brief Summary: A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA CAR-NK cell injection in patients with refractory pediatric rheumatic diseases.

Study Start Date: March 19

Study Type: INTERVENTIONAL

Condition: Rheumatic Diseases Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese) Systemic Lupus Erythematosus (SLE) Connective Tissue Disease-associated Interstitial Lung Disease...